Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, January 15th. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00. Following the completion of the sale, the president owned 1,027,015 shares of the company’s stock, valued at $23,087,297.20. This trade represents a 2.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.33, for a total transaction of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total transaction of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.01, for a total value of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.02, for a total value of $333,953.62.

Alignment Healthcare Stock Performance

Shares of NASDAQ ALHC remained flat at $22.50 during mid-day trading on Friday. The stock had a trading volume of 3,345,207 shares, compared to its average volume of 2,831,083. The company’s fifty day moving average is $19.08 and its two-hundred day moving average is $16.76. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.19. The stock has a market cap of $4.50 billion, a PE ratio of -187.50, a PEG ratio of 5.73 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The firm had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. During the same quarter in the prior year, the business earned ($0.14) earnings per share. The company’s revenue was up 43.5% on a year-over-year basis. Research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ALHC. Larson Financial Group LLC bought a new position in Alignment Healthcare in the third quarter worth $33,000. GAMMA Investing LLC raised its stake in shares of Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after buying an additional 987 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Alignment Healthcare during the 3rd quarter worth about $53,000. SBI Securities Co. Ltd. boosted its position in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares in the last quarter. Finally, KBC Group NV bought a new stake in Alignment Healthcare in the second quarter valued at about $44,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on ALHC. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. Barclays boosted their price objective on Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, October 31st. JPMorgan Chase & Co. raised their target price on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a report on Monday, November 24th. Finally, UBS Group raised their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $21.86.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.